The Canadian government reduced the reimbursement rate for medicinal cannabis prescriptions for veterans with PTSD and chronic pain in April [1].

This policy change affects veterans who rely on medicinal cannabis to manage severe mental health conditions and long-term physical injuries. The reduction in financial support may force patients to pay higher out-of-pocket costs for their prescribed medication.

Veterans Affairs Canada lowered the reimbursement from $8.50 [1] to $6.00 [1] per gram. The government said the decision was based on concerns regarding the overall cost of medicinal cannabis reimbursements [1].

The shift impacts a specific population of former service members dealing with post-traumatic stress disorder and chronic pain. Because these conditions often require consistent medication levels, the $2.50 per gram difference could lead to significant monthly expenses for those on high-dosage regimens.

Government officials have not provided a specific timeline for reviewing these rates in the future. The current policy remains in effect across Canada, altering how the state subsidizes cannabis as a medical treatment for those who served in the armed forces [1].

“The Canadian government reduced the reimbursement rate for medicinal cannabis prescriptions for veterans.”

The reduction in reimbursement reflects a tightening of fiscal policy regarding the cost of specialized medical treatments. For veterans, this creates a gap between government subsidies and the market price of medical-grade cannabis, potentially limiting access for those unable to afford the difference.